News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News News 07/10/2021 IrsiCaixa is working on the development of synthetic antibodies to prevent SARS-CoV-2 infection thanks to the support of the Gloria Soler Foundation 28/09/2021 Two IrsiCaixa researchers will be part of the Scientific Advisory Committee of COVID-19 of the Department of Health 22/09/2021 SARS-CoV-2 can infect and spread better thanks to lectins, molecules present in immune system cells 21/09/2021 VIRIEVAC takes part in the European Science Night 2021 21/09/2021 Treating with Remdesivir immediately after diagnosis of COVID-19 reduces the risk of hospitalization and death in vulnerable patients with severe disease by 87% 19/09/2021 COVID vaccines: do we need a booster dose at this time? 14/09/2021 An IrsiCaixa project to diagnose and monitor infectious diseases, among the selected projects by the CaixaResearch Validate 2021 call 15/08/2021 SARS-CoV-2 infection generates protective antibodies that are maintained beyond one year 08/08/2021 The Beta variant goes beyond humans and also infects mice, unlike the original SARS-CoV-2 Pagination First Previous Page 1 Page 2 Page 3 Page 4 5 Page 6 Page 7 Page 8 Page 9 … Next Last
07/10/2021 IrsiCaixa is working on the development of synthetic antibodies to prevent SARS-CoV-2 infection thanks to the support of the Gloria Soler Foundation
28/09/2021 Two IrsiCaixa researchers will be part of the Scientific Advisory Committee of COVID-19 of the Department of Health
22/09/2021 SARS-CoV-2 can infect and spread better thanks to lectins, molecules present in immune system cells
21/09/2021 Treating with Remdesivir immediately after diagnosis of COVID-19 reduces the risk of hospitalization and death in vulnerable patients with severe disease by 87%
14/09/2021 An IrsiCaixa project to diagnose and monitor infectious diseases, among the selected projects by the CaixaResearch Validate 2021 call
